Neurogastrx
Jim brings to Neurogastrx decades of biotech industry experience, and more than 10 years in gastrointestinal drug development and commercialization with the IBS product LINZESS® at Ironwood Pharmaceuticals. Among Jim’s notable contributions are numerous LINZESS deals he closed in the US, Europe, Japan and China. Prior to joining Ironwood, Jim was Vice President, Corporate Development for Cozint Interactive, one of the first on-line market intelligence companies. Jim began his biotech career at MPM Capital, where he focused on business development transactions for emerging biotech companies. He has a Bachelor of Science in Pharmacy from the Massachusetts College of Pharmacy.
This person is not in any offices
Neurogastrx
Neurogastrx is a specialty pharmaceutical company developing transformative therapies to advance the treatment of gastrointestinal (GI) disorders. They focus on developing treatments for GI disorders for which meaningful therapeutic innovation is required to satisfy unmet patient need and disease burden.